Research purposes only.
All our research peptides come in lyphollized/powder form and must be reconstituted to a liquid for researching and testing.
3rd party tested for purity.
Ret@ (aka Ret@trut!de) is a novel triple agonist peptide researched to treat obesity and type 2 diabetes in test subjects.
Ret@ functions by acting on three different hormone receptors: GLP-1, GIP, and glucagon. This triple-action mechanism addresses blood sugar control and weight management by influencing multiple pathways involved in appetite, energy use, and glucose regulation.